Lamotrigin Hexal (Lamotrigine)

Lamotrigine works by blocking voltage‑gated sodium channels on neurons. This action stabilises neuronal membranes and reduces the release of excitatory neurotransmitters such as glutamate, helping to prevent the excessive electrical activity that leads to seizures and mood swings.

The dose of Lamotrigin Hexal is individualized by the prescribing clinician based on the patient’s age, weight, renal and hepatic function, and the specific condition being treated. The prescriber will determine the starting dose and any titration schedule needed to achieve therapeutic effect while minimising side‑effects.

Safety data for lamotrigine in pregnancy are limited, and the medication is classified as pregnancy category unknown. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider, who can weigh seizure control against possible fetal exposure.

To request Lamotrigin Hexal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamotrigin Hexal offers a distinct mechanism—sodium‑channel blockade—different from many older antiepileptics such as carbamazepine or phenytoin. It is often preferred for its relatively favourable cognitive profile and lower risk of certain enzyme‑inducing interactions, though individual response and tolerability vary.

Lamotrigin Hexal should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain stability and potency throughout its shelf life.

Lamotrigin Hexal is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias, hepatic failure, and the emergence of suicidal thoughts or behaviours. Prompt medical attention is required if any of these symptoms develop.

Lamotrigin Hexal is contraindicated in patients with a known hypersensitivity to lamotrigine or any of its excipients. Caution is also advised for individuals with a history of severe skin reactions, significant liver disease, or those taking interacting medications that could markedly alter lamotrigine levels.